Hjem › Overvægt › Indiana › Indianapolis
Overvægt kliniske forsøg i Indianapolis, IN
13 studier for Overvægt søger deltagere på steder i og omkring Indianapolis (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
RekruttererFase 3
- IU Health - Riley Physicians Endo-Diab, Indianapolis
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
RekruttererFase 3
- Midwest Inst For Clin Res, Indianapolis
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
RekruttererFase 3
- Midwest Inst For Clin Res, Indianapolis
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RekruttererFase 3
- Indiana University Health University Hospital, Indianapolis
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RekruttererFase 3
- Riley Hospital for Children, Indianapolis
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RekruttererFase 3
- Indiana University Health University Hospital, Indianapolis
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RekruttererFase 3
- DM Clinical Research - Indianapolis, Indianapolis
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
RekruttererFase 3
- AURORA-1 Clinical Site, Indianapolis
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RekruttererFase 3
- AURORA-2 Clinical Site, Indianapolis
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
RekruttererFase 2
- Investigators Research Group, Brownsburg · 14 mi væk
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
RekruttererFase 4
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
- The Indiana Clinical Trials Center, PC, Plainfield · 14 mi væk
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
RekruttererFase 3
- Midwest Inst For Clin Res, Indianapolis
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
Rekrutterer
- Indiana University, Indianapolis
Overvægt forsøg i andre byer
- San Antonio, TX34 studier
- Houston, TX33 studier
- Chicago, IL28 studier
- Orlando, FL27 studier
- Las Vegas, NV23 studier
- Miami, FL23 studier
- Atlanta, GA20 studier
- Dallas, TX20 studier
- New York City, NY19 studier
- Jacksonville, FL19 studier
- Washington, DC19 studier
- Austin, TX18 studier
Andre studier i Indianapolis
- Ikke-småcellet lungecancer32 studier
- Kræft (alle typer)24 studier
- Hjertesvigt23 studier
- Brystkræft20 studier
- Overvægt20 studier
- Metastatisk cancer19 studier
- Colorektal kræft18 studier
- Ægstockræft17 studier
- Lungecancer16 studier
- Kardiovaskulær sygdom16 studier
- Type 1-diabetes14 studier
- Livmoderslimhindekræft14 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.